Lynparza is a poly (ADP-ribose) polymerase (PARP) inhibitor indicated:
Ovarian cancer
• for the maintenance treatment of adult patients with recurrent epithelial
ovarian, fallopian tube or primary peritoneal cancer, who are in a
complete or partial response to platinum-based chemotherapy.
• for the treatment of adult patients with deleterious or suspected
deleterious germline BRCA-mutated (gBRCAm) advanced ovarian
cancer who have been treated with three or more prior lines of
chemotherapy. Select patients for therapy based on an FDA-approved
companion diagnostic for Lynparza.
Breast cancer
• in patients with deleterious or suspected deleterious gBRCAm, human
epidermal growth factor receptor 2 (HER2)-negative metastatic breast
cancer who have previously been treated with chemotherapy in the
neoadjuvant, adjuvant or metastatic setting. Patients with hormone
receptor (HR)-positive breast cancer should have been treated with a
prior endocrine therapy or be considered inappropriate for endocrine
treatment. Select patients for therapy based on an FDA-approved
companion diagnostic for Lynparza.
Olaparib, sold under the brand name Lynparza, is a medication for the maintenance treatment of BRCA-mutated advanced ovarian cancer in adults. It is a PARP inhibitor, inhibiting poly ADP ribose polymerase (PARP), an enzyme involved in DNA repair. It acts against cancers in people with hereditary BRCA1 or BRCA2 mutations, which include some ovarian, breast, and prostate cancers.
Please contact at +91 9910645395 or send your enquiry at info@cancermedicinesnetwork to find the price of LYNPARZA® (olaparib) tablets, for oral use in Vietnam, Philippines and Ireland. We take guarantee of quality and delivery as per the buyer’s requirements.
To buy LYNPARZA (olaparib) tablets in India, request you to send your details via query form or you can call or WhatsApp (+91) 9910645395 or send mail to urgent@cancermedicinesnetwork.com to know the best price. We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Yes, Verve Biosciences can assist in the delivery of LYNPARZA (olaparib) tablets, doctor prescribed medicine. The Order Will Be Confirmed Only After The Receipt Of Valid prescription of Doctor and Import permit if applicable.
Verve Biosciences have exported LYNPARZA (olaparib) tablets in China, UAE, Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.